The durability of the first injection was also influenced by baseline visual acuity, even after adjusting for recalcitrant vs recurrent disease, with every one-line worse baseline vision having a 30-day shorter durability, though this was only marginally significant.
← all excerpts
Switching to Faricimab for Polypoidal Choroidal Vasculopathy with Real-World Outcomes in Refractory Cases - The FAR-PEARL Study Report 1.
1
—
—